164 related articles for article (PubMed ID: 31344718)
21. Ovarian Sertoli-Leydig cell tumors: a single institution experience and review of the literature.
Gressel GM; Buza N; Pal L
Eur J Gynaecol Oncol; 2017; 38(2):214-220. PubMed ID: 29953783
[TBL] [Abstract][Full Text] [Related]
22. Sertoli-Leydig cell tumor of the ovary: a clinicopathologic study of 10 cases.
Ayhan A; Tuncer ZS; Hakverdi AU; Yüce K; Ayhan A
Eur J Gynaecol Oncol; 1996; 17(1):75-8. PubMed ID: 8750520
[TBL] [Abstract][Full Text] [Related]
23. Pediatric ovarian Sertoli-Leydig cell tumors with heterologous rhabdomyosarcoma elements: Clinical case series and review of the literature.
Koo J; Garrington TP; Kerr K; Treece AL; Cost CR
Pediatr Blood Cancer; 2020 Oct; 67(10):e28621. PubMed ID: 32729194
[TBL] [Abstract][Full Text] [Related]
24. DICER1 Mutations Are Consistently Present in Moderately and Poorly Differentiated Sertoli-Leydig Cell Tumors.
de Kock L; Terzic T; McCluggage WG; Stewart CJR; Shaw P; Foulkes WD; Clarke BA
Am J Surg Pathol; 2017 Sep; 41(9):1178-1187. PubMed ID: 28654427
[TBL] [Abstract][Full Text] [Related]
25. Moderately differentiated Sertoli-Leydig cell tumor of ovary with associated mucinous carcinoma and carcinoid-A case report and review of literature.
Ravichandaran A; Lakshmanan A; Kurian A; Prasad S
Indian J Pathol Microbiol; 2021; 64(3):528-531. PubMed ID: 34341265
[TBL] [Abstract][Full Text] [Related]
26. Unclassified ovarian gonadal stromal tumors. A clinicopathologic study of 32 cases.
Seidman JD
Am J Surg Pathol; 1996 Jun; 20(6):699-706. PubMed ID: 8651349
[TBL] [Abstract][Full Text] [Related]
27. Ovarian Sertoli-Leydig cell tumor with heterologous elements of gastrointestinal type associated with elevated serum alpha-fetoprotein level: an unusual case and literature review.
Horta M; Cunha TM; Marques RC; Félix A
J Radiol Case Rep; 2014 Nov; 8(11):30-41. PubMed ID: 25926909
[TBL] [Abstract][Full Text] [Related]
28. DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors.
Karnezis AN; Wang Y; Keul J; Tessier-Cloutier B; Magrill J; Kommoss S; Senz J; Yang W; Proctor L; Schmidt D; Clement PB; Gilks CB; Huntsman DG; Kommoss F
Am J Surg Pathol; 2019 May; 43(5):628-638. PubMed ID: 30986800
[TBL] [Abstract][Full Text] [Related]
29. [Clinical analysis of 11 cases of ovarian Setoli-Leydig cell tumor].
Li B; Wu LY; Zhang WH; Li L; Ma SK; Liu LY
Zhonghua Fu Chan Ke Za Zhi; 2004 May; 39(5):334-7. PubMed ID: 15196418
[TBL] [Abstract][Full Text] [Related]
30. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin.
Gershenson DM; Morris M; Burke TW; Levenback C; Matthews CM; Wharton JT
Obstet Gynecol; 1996 Apr; 87(4):527-31. PubMed ID: 8602303
[TBL] [Abstract][Full Text] [Related]
31. Mucinous adenocarcinoma as heterologous element in intermediately differentiated Sertoli-Leydig cell tumor of the ovary.
Virk R; Lu D
Pathol Res Pract; 2010 Jul; 206(7):489-92. PubMed ID: 19674851
[TBL] [Abstract][Full Text] [Related]
32. Clinical Characteristics and Mutation Analyses of Ovarian Sertoli-Leydig Cell Tumors.
Yuan Z; Huo X; Jiang D; Yu M; Cao D; Wu H; Shen K; Yang J; Zhang Y; Zhou H; Wang Y
Oncologist; 2020 Sep; 25(9):e1396-e1405. PubMed ID: 32557933
[TBL] [Abstract][Full Text] [Related]
33. Detection of the DICER1 hotspot mutation alongside immunohistochemical analysis may provide a better diagnostic measure for ovarian Sertoli-Leydig cell tumors.
Zhang X; Shen D; Wang Y
Pathol Res Pract; 2018 Sep; 214(9):1370-1375. PubMed ID: 30072170
[TBL] [Abstract][Full Text] [Related]
34. Imaging of gynecological disease (2): clinical and ultrasound characteristics of Sertoli cell tumors, Sertoli-Leydig cell tumors and Leydig cell tumors.
Demidov VN; Lipatenkova J; Vikhareva O; Van Holsbeke C; Timmerman D; Valentin L
Ultrasound Obstet Gynecol; 2008 Jan; 31(1):85-91. PubMed ID: 18098335
[TBL] [Abstract][Full Text] [Related]
35. Poorly differentiated, ovarian Sertoli-Leydig cell tumor with heterologous rhabdomyosarcoma and glandular elements: Diagnosis and management of a rare neoplasm.
Singh C; Ahmad S; Hajjar FM; Holloway RW
Gynecol Oncol Rep; 2018 Aug; 25():70-73. PubMed ID: 29922708
[TBL] [Abstract][Full Text] [Related]
36. A novel clinicopathological analysis of early stage ovarian Sertoli-Leydig cell tumors at a single institution.
Nam SM; Kim JW; Eoh KJ; Kim HM; Lee JY; Nam EJ; Kim S; Kim SW; Kim YT
Obstet Gynecol Sci; 2017 Jan; 60(1):39-45. PubMed ID: 28217670
[TBL] [Abstract][Full Text] [Related]
37. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
38. Sertoli-Leydig cell tumor of ovary in children: A report of two cases, including retiform variant.
Sarkar P; Sengupta M; Chatterjee U; Ghosh D
Indian J Pathol Microbiol; 2021; 64(3):559-562. PubMed ID: 34341273
[TBL] [Abstract][Full Text] [Related]
39. Ovarian Sertoli-Leydig tumor: A tricky tumor case report.
Khalloufi C; Joudar I; Kanas A; Benhessou M; Ennachit M; El Kerroumi M
Int J Surg Case Rep; 2023 Apr; 105():108043. PubMed ID: 36989630
[TBL] [Abstract][Full Text] [Related]
40. Sertoli - Leydig cell tumor with retiform areas and overgrowth of rhabdomyosarcomatous elements: case report and literature review.
Burnik Papler T; Frković Grazio S; Kobal B
J Ovarian Res; 2016 Jul; 9(1):46. PubMed ID: 27473538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
